Background The diagnosis of cardiac amyloidosis can be established non-invasively by
scintigraphy using bone-avid tracers, but visual assessment is subjective and can lead to …

Aim Tricuspid regurgitation secondary to heart failure (HF) is common with considerable
impact on survival and hospitalization rates. Currently, insights into epidemiology, impact, and …

The prevalence of cardiac amyloidosis (CA) in the general population and associated
prognostic implications remain poorly understood. We aimed to identify CA prevalence and …

Background: Dual pathology of severe aortic stenosis (AS) and transthyretin cardiac amyloidosis
(ATTR) is increasingly recognized. Evolution of symptoms, biomarkers, and myocardial …

Aims Cardiac decompensation in aortic stenosis (AS) involves extra‐valvular cardiac damage
and progressive fluid overload (FO). FO can be objectively quantified using bioimpedance …

Background Mitral regurgitation (MR) and cardiac amyloidosis (CA) both primarily affect
older patients. Data on coexistence and prognostic implications of MR and CA are currently …

Transcatheter aortic valve replacement (TAVR) has established itself as a safe and efficient
treatment option in patients with severe aortic valve stenosis, regardless of the underlying …

Diagnostic advances and disease awareness have resulted in an increased recognition of
cardiac amyloidosis (CA). Broader use of bone scintigraphy for screening of transthyretin (…

Aims Bioprosthetic valve dysfunction (BVD) is a major concern regarding transcatheter aortic
valve implantation (TAVI) durability. We aimed to assess incidence, correlates, causes, and …

Introduction: Severe tricuspid regurgitation (TR) is a common condition promoting right heart
failure and is associated with a poor long-term prognosis. Transcatheter tricuspid valve …